PRIAS publications
Wed 07 Jun 2023 (819 )
Prias publications and links: Tohi Y et al. Clinical outcomes of intraductal carcinoma or cribriform in radical prostatectomy specimens of men opting for active surveillance: data from the PRIAS-JAPAN study. Int J Clin Oncol. 2023 Feb https://doi.org/10.1007/s10147-022-02277-8 Kato T et al. Comparison of the medical costs between active surveillance and other treatments for early prostate cancer in Japan using data from the PRIAS-JAPAN study. Int J Urol. 2022 Nov https://doi.org/10.1111/iju.14977 Dordoni P et al. Cross-cultural differences in men on active surveillance' anxiety: a longitudinal comparison between Italian and Dutch patients from the Prostate cancer Research International Active Surveillance study. BMC Urol. 2022 Jul https://doi.org/10.1186/s12894-022-01062-z Tohi Y et al. Impact of adherence to criteria on oncological outcomes of radical prostatectomy in patients opting for active surveillance: data from the PRIAS-JAPAN study. Jpn J Clin Oncol. 2022 Sep https://doi.org/10.1093/jjco/hyac092 Beyer K et al. Secondary Treatment for Men with Localized Prostate Cancer: A Pooled Analysis of PRIAS and ERSPC-Rotterdam Data within the PIONEER Data Platform. J Pers Med. 2022 May https://doi.org/10.3390/jpm12050751 Luiting HB et al. A Multivariable Approach Using Magnetic Resonance Imaging to Avoid a Protocol-based Prostate Biopsy in Men on Active Surveillance for Prostate Cancer-Data from the International Multicenter Prospective PRIAS Study. Eur Urol Oncol. 2022 Dec https://doi.org/10.1016/j.euo.2022.03.007 Tohi Y et al. Deferred radical prostatectomy in patients who initially elected for active surveillance: a multi-institutional, prospective, observational cohort of the PRIAS-JAPAN study. Int J Clin Oncol. 2022 Jan https://doi.org/10.1007/s10147-021-02041-4 Kato T et al. Reclassification prediction of first-year protocol biopsy on active surveillance of prostate cancer by p2PSA-related parameters: from PRIAS-JAPAN. Prostate Cancer Prostatic Dis. 2022 Apr https://doi.org/10.1038/s41391-021-00422-4 Lokman U et al. Prospective Longitudinal Health-related Quality of Life Analysis of the Finnish Arm of the PRIAS Active Surveillance Cohort: 11 Years of Follow-up. Eur Urol Focus. 2022 Sep https://doi.org/10.1016/j.euf.2021.06.008 Tohi Y et al. Impact of health-related quality of life on repeat protocol biopsy compliance on active surveillance for favorable prostate cancer: results from a prospective cohort in the PRIAS-JAPAN study. Urol Oncol. 2022 Feb https://doi.org/10.1016/j.urolonc.2021.05.003 Luiting HB et al. What is the effect of MRI with targeted biopsies on the rate of patients discontinuing active surveillance? A reflection of the use of MRI in the PRIAS study. Prostate Cancer Prostatic Dis. 2021 Dec https://doi.org/10.1038/s41391-021-00343-2 Alvisi MF et al. Supporting Patients With Untreated Prostate Cancer on Active Surveillance: What Causes an Increase in Anxiety During the First 10 Months? Front Psychol. 2020 Nov https://doi.org/10.3389/fpsyg.2020.576459 Hirama H et al. Health-related quality of life in Japanese low-risk prostate cancer patients choosing active surveillance: 3-year follow-up from PRIAS-JAPAN. World J Urol. 2021 Jul https://doi.org/10.1007/s00345-020-03494-4 Tohi Y et al. The impact of complications after initial prostate biopsy on repeat protocol biopsy acceptance rate. Results from the Prostate Cancer Research International: Active Surveillance JAPAN study. Int J Clin Oncol. 2020 Dec https://doi.org/10.1007/s10147-020-01761-3 Tomer A et al. Personalised biopsy schedules based on risk of Gleason upgrading for patients with low-risk prostate cancer on active surveillance. BJU Int. 2021 Jan https://doi.org/10.1111/bju.15136 Tomer A et al. Personalized Decision Making for Biopsies in Prostate Cancer Active Surveillance Programs. Med Decis Making. 2019 Jul https://doi.org/10.1177/0272989x19861963 Menichetti J et al. Making Active Surveillance a path towards health promotion: A qualitative study on prostate cancer patients' perceptions of health promotion during Active Surveillance. Eur J Cancer Care (Engl). 2019 May https://doi.org/10.1111/ecc.13014 Tomer A et al. Personalized schedules for surveillance of low-risk prostate cancer patients. Biometrics. 2019 Mar https://doi.org/10.1111/biom.12940 Schoots IG et al. Reduction of MRI-targeted biopsies in men with low-risk prostate cancer on active surveillance by stratifying to PI-RADS and PSA-density, with different thresholds for significant disease. Transl Androl Urol. 2018 Feb https://doi.org/10.21037/tau.2017.12.29 Drost FH et al. Can active surveillance really reduce the harms of overdiagnosing prostate cancer? A reflection of real life clinical practice in the PRIAS study. Transl Androl Urol. 2018 Feb https://doi.org/10.21037/tau.2017.12.28 Marenghi C et al. Eleven-year management of prostate cancer patients on active surveillance: what have we learned? Tumori. 2017 Sep https://doi.org/10.5301/tj.5000649 Alvisi MF et al. Italian cultural adaptation of the Memorial Anxiety for Prostate Cancer scale for the population of men on active surveillance. Tumori. 2018 Jun https://doi.org/10.5301/tj.5000646 Bokhorst LP et al. Effect of pathologic revision and Ki67 and ERG immunohistochemistry on predicting radical prostatectomy outcome in men initially on active surveillance. Prostate. 2017 Jul https://doi.org/10.1002/pros.23372 Bokhorst LP et al. A Decade of Active Surveillance in the PRIAS Study: An Update and Evaluation of the Criteria Used to Recommend a Switch to Active Treatment. Eur Urol. 2016 Dec https://doi.org/10.1016/j.eururo.2016.06.007 Bokhorst LP et al. Complications after prostate biopsies in men on active surveillance and its effects on receiving further biopsies in the Prostate cancer Research International: Active Surveillance (PRIAS) study. BJU Int. 2016 Sep https://doi.org/10.1111/bju.13410 Bokhorst LP et al. Compliance Rates with the Prostate Cancer Research International Active Surveillance (PRIAS) Protocol and Disease Reclassification in Noncompliers. Eur Urol. 2015 Nov;68(5):814-21. doi: 10.1016/j.eururo.2015.06.012. Epub 2015 Jun https://doi.org/10.1016/j.eururo.2015.06.012 Vasarainen H et al. Predictive role of free prostate-specific antigen in a prospective active surveillance program (PRIAS). World J Urol. 2015 Nov https://doi.org/10.1007/s00345-015-1542-3 Sugimoto M et al. Should inclusion criteria for active surveillance for low-risk prostate cancer be more stringent? From an interim analysis of PRIAS-JAPAN. World J Urol. 2015 Jul https://doi.org/10.1007/s00345-014-1453-8 Bellardita L et al. Predictors of health-related quality of life and adjustment to prostate cancer during active surveillance. Eur Urol. 2013 Jul https://doi.org/10.1016/j.eururo.2013.01.009 Vasarainen H et al. Diffusion-weighted magnetic resonance imaging in prostate cancer patients on active surveillance one year after diagnosis and before repeat biopsy. Scand J Urol. 2013 Dec https://doi.org/10.3109/21681805.2013.765910 Bul M et al. Active surveillance for low-risk prostate cancer worldwide: the PRIAS study. Eur Urol. 2013 Apr https://doi.org/10.1016/j.eururo.2012.11.005 Bangma CH et al. The Prostate cancer Research International: Active Surveillance study. Curr Opin Urol. 2012 May https://doi.org/10.1097/mou.0b013e328351dcc7 Bul M et al. Radical prostatectomy for low-risk prostate cancer following initial active surveillance: results from a prospective observational study. Eur Urol. 2012 Aug https://doi.org/10.1016/j.eururo.2012.02.002 Vasarainen H et al. Prostate cancer active surveillance and health-related quality of life: results of the Finnish arm of the prospective trial. BJU Int. 2012 Jun https://doi.org/10.1111/j.1464-410x.2011.10677.x van den Bergh RC et al. Short-term outcomes of the prospective multicentre 'Prostate Cancer Research International: Active Surveillance' study. BJU Int. 2010 Apr https://doi.org/10.1111/j.1464-410x.2009.08887.x van den Bergh RC et al. Disease insight and treatment perception of men on active surveillance for early prostate cancer. BJU Int. 2010 Feb https://doi.org/10.1111/j.1464-410x.2009.08764.x van den Bergh RC et al. Prospective validation of active surveillance in prostate cancer: the PRIAS study. Eur Urol. 2007 Dec https://doi.org/10.1016/j.eururo.2007.05.011

:: Print ::